In the last decade, several studies attempted to demonstrate the connection between polymorphisms of angiogenesis-related factors (VEGF, VEGFR-2, RET, EGF, TGF-β) genes and pancreatic tumours [6,8,9,27,28]. This evidence concerns the gene EGF and pancreatic neoplasm.